MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-03-2023
Axcella Health P/CF Ratio 2011-2026 | AXLA
Annual P/CF Ratio Axcella Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.359 | -1.2 | -4.02 | -1.58 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.359 | -4.02 | -1.79 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M |  USA |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M |  Canada |
 |
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | USA |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | France |
 |
Ascendis Pharma A/S
ASND
|
-17.6 | $ 220.9 | 2.49 % | $ 5 B |  Danmark |
 |
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | USA |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
8 | $ 19.57 | 1.77 % | $ 915 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M |  Israel |
 |
CytomX Therapeutics
CTMX
|
-12.3 | - | - | $ 582 M | USA |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | USA |
 |
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | USA |
 |
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
bluebird bio
BLUE
|
-0.285 | - | - | $ 546 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Cara Therapeutics
CARA
|
-0.588 | - | -3.03 % | $ 260 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.33 | 0.76 % | $ 339 M | Britain |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-1.97 | $ 8.31 | 1.59 % | $ 111 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
-12.7 | $ 47.09 | 1.42 % | $ 4.23 B |  Schweiz |
 |
Cyclacel Pharmaceuticals
CYCC
|
-0.698 | - | -5.98 % | $ 34.1 M | USA |
 |
ChemoCentryx
CCXI
|
-0.024 | - | - | $ 3.74 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
26 | - | - | $ 2.02 B | USA |
 |
Eton Pharmaceuticals
ETON
|
53.1 | $ 23.84 | 3.79 % | $ 641 M | USA |
 |
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | USA |
 |
Enochian Biosciences
ENOB
|
-14.7 | - | - | $ 40.5 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Fortress Biotech
FBIO
|
-0.404 | $ 2.99 | 2.4 % | $ 62.1 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
-4.42 | - | -74.18 % | $ 955 K | USA |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
-21.4 | $ 4.53 | 5.1 % | $ 868 M | Canada |
 |
Homology Medicines
FIXX
|
-0.672 | - | 0.77 % | $ 53.4 M | USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | USA |
 |
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | USA |
 |
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-3.33 | - | - | $ 384 M | Britain |